Listen: Biden’s plans for biopharma, a CES preview, & the next phase of the pandemic

What does a Democratic Senate portend for the drug industry? Is software eating health care? And can Covid-19 vaccines withstand viral mutations?

We discuss all that and more on this week’s episode of “The Readout LOUD,” STAT’s biotech podcast. First, STAT Washington correspondent Lev Facher joins us to break down the implications of a Democrat-controlled Senate — and the aftermath of pro-Trump rioting at the Capitol. Then, our colleague Erin Brodwin calls in to talk about CES, the massive tech conference taking place next week, and what it portends for that sector’s embrace of health care. Finally, we chat with Bob Nelsen, a biotech venture capitalist and one of the few people who saw the coming pandemic with clarity months before everyone else, about what’s ahead in 2021.

For more on what we cover, here’s more on President-elect Biden’s plans for 2021; here’s where you can find STAT’s CES reporting; here’s more on Nelsen’s latest company; and here’s our complete coverage of the coronavirus pandemic.

advertisement

Be sure to sign up on Apple PodcastsStitcherGoogle Play, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

advertisement


Interested in sponsoring a future episode of “The Readout LOUD”? Email us at [email protected].

Source: STAT